People living with a serious chronic disease are experts by experience. By sharing their experience, they help us improve the future of healthcare.
More than 25,000 people participate in our clinical trials each year. They are one of the most important steps to finding new medicines.
Look at our future science
Review our clinical pipeline
What is a clinical trial and how to participate
We believe that a healthy environment, society and economy are fundamental to long-term business success, and we will play our part, also on the long-term.
Find answers to some of the more frequently asked questions on sustainability and responsible business practices.
Two different monoclonal GLP-1 receptor antibodies developed by Novo
Nordisk are available at the Developmental Studies Hybridoma Bank at
the University of Iowa.
The antibodies can be acquired via the two links below.
Anti-GLP-1R, clone 3F52:
Anti-GLP-1R, clone 7F38:
These tool antibodies will not be in stock for ordering via this
website, but feel free to sign up for Compound Sharing Updates to stay
informed when other compounds are added to the list of available compounds.